IP Library Granted Patent US 8,818,734
Granted Patent B1
US 8,818,734 · App. 13/300,195 · Granted Aug 26, 2014

Peptide ligands for sperm DNA fragmentation assay

Inventors: Dagan Wells (Oxford, GB); Jacques Cohen (New York, NY); George Pieczenik (Stockton, NJ)
G01N33/50G01N33/58G01N33/5091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,818,734
App. No.
13/300,195
Granted
Aug 26, 2014
Kind
B1
Abstract

This invention comprises peptides, methods and a kit for identifying DNA fragmentation in non-viable sperm. Specific peptide sequences are claimed that bind to ssDNA and fragmented DNA.

Claims (15)

1. A ssDNA binding peptide comprising the sequence of SEQ ID NO:2.

2. The peptide of claim 1 , further comprising an attached chromophore.

3. A viable sperm determining kit comprising Annexin V and a ssDNA and fragmented DNA binding peptide comprising the peptide of SEQ ID NO:2.

4. A method of detecting viable sperm comprising the steps of:

a) staining sperm with chromophore labeled Annexin V and,

b) staining sperm with a different chromophore labeled peptide of SEQ ID 2 and,

c) identifying those sperm not stained which are viable.

5. A method of detecting viable sperm comprising the steps of:

a) staining the sperm with a dye selected from Hoecht, DAPI, and Sytox Green to determine viability, and

b) staining additionally with the peptide of SEQ ID NO:2; and,

c) identifying those viable sperm which do not stain with the peptide of SEQ ID NO:2.

6. A method of intracytoplasmic sperm injection comprising

a) adding a peptide of claim 2 to human sperm and,

b) removing microsurgically a non-stained human sperm; and,

c) inserting said non-stained human sperm into an oocyte.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2015
From: WELLS, DAGAN; COHEN, JACQUES
To: REPROGENETICS, LLC
Reel/Frame 036617/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2015
From: PIECZENIK, GEORGE
To: TYHO-GALILEO RESEARCH LABORATORIES LLC
Reel/Frame 036610/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2015
From: COHEN, JACQUES
To: REPROGENETICS, LLC
Reel/Frame 036610/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2015
From: TYHO-GALILEO RESEARCH LABORATORIES, LLC
To: REPROGENETICS, LLC
Reel/Frame 036610/0095 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2015
From: GCI CAPITAL MARKETS LLC, AS ADMINISTRATIVE AGENT
To: REPROGENETICS, LLC
Reel/Frame 036286/0900 →
CORRECTION BY DECLARATION OF INCORRECT APPLICATION NUMBER 13,300,195, RECORDED AT REEL 34506, FRAME 0293 Recorded Jul 8, 2015
From: PIECZENIK, GEORGE, DR.
To: PIECZENIK, GEORGE, DR
Reel/Frame 036233/0412 →
SECURITY INTEREST Recorded Dec 17, 2014
From: REPROGENETICS, LLC
To: GCI CAPITAL MARKETS LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 034528/0558 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2014
From: WELLS, DAGAN; COHEN, JACQUES; PIECZENIK, GEORGE
To: REPROGENETICS, LLC
Reel/Frame 034506/0288 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2014
From: REPROGENETICS, LLC, A NEW JERSEY LIMITED LIABILITY COMPANY
To: REPROGENETICS, LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 034506/0460 →